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used pacing protocols for 2 to 4 weeks. Several recent
studies have assessed the short-term recovery (typically
1 month) after cessation of pacing.1,3-5,8-15 Unfortunately,
they have shown that termination of rapid ventricular
pacing results in a rapid normalization of load-sensitive
indices of global cardiac function, neurohumoral pro-
files, and hemodynamics, whereas abnormalities of car-
diac size and individual myocyte function persist.
We hypothesized that prolonging the insult to the
myocardium would result in more significant changes
in the cellular and molecular processes inducing HF in
this model, and more severe permanent LV dysfunction
would then result. Accordingly, this study was conduct-
ed to assess the long-term recovery after prolonged
rapid ventricular pacing. This study used serial echocar-
diography and pressure-volume (PV) analysis to obtain
novel longitudinal information about cardiac function,
volumes, and energetics after cessation of prolonged
rapid ventricular pacing.
Material and methods
All animals used in this study received care in compliance
with the “Guide for the Care and Use of Laboratory Animals”
T o study new surgical therapies for end-stage dilatedcardiomyopathy, a stable, long-term animal model
analogous to the human condition needs to be devel-
oped. One potential model is rapid ventricular pacing.
This model produces a reliable model of left ventricular
(LV) dysfunction and leads to heart failure (HF) within
1 to 2 weeks of initiating pacing.1-6 Congestive HF
develops with signs of venous congestion, systolic and
diastolic LV dysfunction, and an increase in ventricular
volumes.1-8 Neurohumoral profiles obtained in this
model have shown abnormalities consistent with an
activated sympathetic system.2,3,9 Most reports have
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tently dilated. We present novel data that show that prolonged rapid
ventricular pacing (10 weeks) creates a model of chronic left ventricular dys-
function.
Methods: In 9 dogs undergoing 10 weeks of rapid ventricular pacing, left
ventricular function and volumes were serially assessed by using 2-dimen-
sional echocardiography and pressure-volume analysis for 12 weeks after
cessation of pacing.
Results: Increased end-diastolic volume and decreased systolic and diastolic
function were seen at the end of pacing. By 2 weeks of recovery from rapid
ventricular pacing, end-diastolic volume and ejection fraction were partially
recovered but did not improve further thereafter. Load-independent and load-
sensitive indices of function obtained by pressure-volume analysis at 8 and
12 weeks of recovery confirmed a persistence of both systolic and diastolic
dysfunction. In addition, left ventricular mass increased with pacing and
remained elevated at 8 and 12 weeks of recovery. Four of these dogs studied
at 6 months of recovery showed similar left ventricular abnormalities.
Conclusion: Ten weeks of rapid ventricular pacing creates a long-term model
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Experimental design. Nine heartworm-free adult mongrel
dogs (22-30 kg) were studied. All dogs underwent baseline 2-
dimensional echocardiography and PV analysis as described
below. After pacemaker implantation, the dogs were subject-
ed to rapid ventricular pacing at 215 beats/min for 10 weeks
to ensure development of HF. At the end of pacing, studies
were repeated in all dogs. Pacemakers were removed at peak
failure (HF). Seven of 9 dogs (2 dogs were killed at the 10-
week study point of rapid ventricular pacing because of com-
plications during data collection) were observed during
recovery from rapid ventricular pacing by using biweekly
echocardiograms for 8 weeks, and a final echocardiogram
was obtained at 12 weeks. PV analysis was conducted in
these 7 dogs at 8 and 12 weeks of recovery. Two additional
dogs underwent echocardiograms and PV analysis only at 12
weeks of recovery. Terminal studies in a subset of these dogs
(n = 4) were carried out at 6 months after cessation of rapid
ventricular pacing. Symptoms of cardiac failure (extremity
edema, ascites, and anorexia) present in all dogs by the time
of peak failure were treated with daily digoxin (0.125 mg)
and furosemide (20 mg) along with thrice weekly aspirin (80
mg) for the last 9 weeks of the rapid pacing period and the
first week of recovery.
Echocardiography. Each animal was mildly sedated with
acepromazine (0.05 mg/kg) before we obtained echocardio-
grams. Two-dimensional transthoracic echocardiograms
taken with an ACUSON 128XP echocardiograph (Acuson
Corporation, Mountain View, Calif) were then obtained under
awake conditions. Both short-axis and apical 4-chamber and
long-axis views were obtained and stored for later analysis. 
Anesthesia. One hour before either PV analyses or pace-
maker insertions, each animal was premedicated intramuscu-
larly with acepromazine (0.1 mg/kg) and glycopyrrolate
(INN: glycopyrronium bromide; 0.001 mg/kg). General anes-
thesia was induced with ketamine (10 mg/kg) and diazepam
(0.5 mg/kg) administered intravenously and maintained after
endotracheal intubation with inhaled oxygen (3 L/min) and
isoflurane (1%-2%). Cefazolin (25 mg/kg administered intra-
venously) was given prophylactically before the skin incision
and again just before the termination of all procedures.
PV analysis. PV analysis was conducted after achievement
of anesthesia as follows. A 7F multielectrode dual-field con-
ductance catheter (Sentron Europe BV, Maastricht, The
Netherlands) and a 5F micromanometer-tipped catheter
(Millar Instruments, Inc, Houston, Tex) were placed under
fluoroscopic guidance along the long axis of the LV cavity by
sterile cutdowns of the carotid and right femoral arteries.
Similarly, 20-mL occlusion catheters (Applied Vascular,
Laguna Hills, Calif) were placed at the junction of the superi-
or and inferior venae cavae with the right atrium through the
right jugular and right femoral veins. A balloon-tipped pul-
monary artery catheter was placed through the left jugular vein.
Volume measurements were obtained by using the conduc-
tance catheter technique.16-22 All hemodynamic signals and
the electrocardiographic tracing were processed by using an
analog amplifier (Gould, Inc, Cleveland, Ohio) digitized at
200 Hz and stored on computer disk for offline analysis.
All data were collected with the ventilator held at end-expi-
ration. For determination of the end-systolic and end-dia-
stolic PV relationships and the preload recruitable stroke
work (PRSW) relationship23 (the slope of stroke work vs end-
diastolic volume [EDV]), the 20-mL balloons in the venae
cavae were temporarily inflated to alter preload, as described
previously. All incisions were then closed primarily.
Pacemaker insertion. After a recovery period of no less
than 3 days after the initial PV analysis, each dog was
administered general anesthesia and underwent placement
of specially modified ventricular pacemakers (model IS-1;
Medtronics, Inc, Minneapolis, Minn) designed to maintain
prolonged pacing rates at 215 beats/min. Through a right
anterior thoracotomy, a 2-cm × 3-cm section of the apical
pericardium was excised, and a unipolar pacing lead
(model IS-1, Medtronics, Inc) was secured to the LV apex.
The lead was then tunneled subcutaneously to a subfascial
pocket under the right rectus abdominis and connected to
the implantable pacemaker. A right thoracostomy tube was
then placed, and all incisions were closed in layers. The
tube was removed after 1 hour while the dog was under
anesthesia. Animals were allowed to recover for at least 7
days, after which pacing was initiated at a rate of 215
beats/min for 10 weeks.
Data analysis. Two-dimensional echocardiographic LV
volumes were calculated by using the modified biplane
Simpson rule.24 Cardiac shape was assessed by examining
the ratio of the short-to-long axis area in diastole. All hemo-
dynamic data were analyzed offline by using custom soft-
ware. Parallel conductance from extracavitary structures was
derived from saline calibration, as previously described.19
Volume gain was set to unity. Measured parameters were
heart rate, stroke volume, peak and end-diastolic LV pres-
sures, and pulmonary artery pressures. Derived parameters
included cardiac output, stroke work, maximum and mini-
mum rates of pressure change (maximum dP/dt and mini-
mum dP/dt), and the time constant of isovolumic pressure
decay (τ). This constant was calculated by using a nonlinear
regression, as previously described.25 The end-systolic and
end-diastolic PV relationships and the PRSW data were
derived by using the caval inflow occlusion data.19 These
curves were obtained from data taken after the initial decline
seen in the LV pressure. All data in which there was a change
in the heart rate of over 5% was discarded to minimize the
effects of cardiovascular reflexes; indices of myocardial ener-
getics, including PV area (correlating with oxygen consump-
tion); external mechanical work (area circumscribed by the
PV loop); and the potential energy (dissipated as heat during
contraction) were obtained from representative end-systolic
and end-diastolic relationships as described by Suga.26
Myocardial mechanical efficiency was defined as the ratio of
the external work to the total PV area.
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Statistical tests were performed by using standard comput-
er software (SigmaStat; Jandel Scientific, San Rafael, Calif;
and STATISTICA; StatSoft Inc, Tulsa, Okla). All data are
expressed as means ± SEM. End-systolic elastance and
PRSW were assessed by using analysis of covariance with
changing covariates (volume axis intercept [Vo] and EDV
axis intercept [Mo]) and repeated measures followed by the
Newman-Keuls multiple comparison method. All other dif-
ferences between time points were assessed by using analysis
of variance with repeated measures followed by the multiple
comparison method of Newman and Keuls.
Results
PV loops obtained from one dog are shown in Fig 1.
These loops are representative of an inflow occlusion
study that was used to calculate end-systolic elastance.
The slope of the end-systolic PV relationship decreased
with 10 weeks of pacing and remained depressed at 3
months of recovery.
Creation of HF. By the end of pacing (HF), LV func-
tion had deteriorated significantly from baseline (Figs
2, 3, and 4). Signs indicative of cardiac failure, includ-
ing ascites, anorexia, inspiratory crackles, and a third
heart sound, were present in all dogs by the end of pac-
ing. Systolic parameters of PRSW, end-systolic elas-
tance, maximum dP/dt, and echocardiographic ejection
fraction were all depressed (PRSW, P = .000003; end-
systolic elastance, P = .000619; maximum dP/dt, P =
.0000008; ejection fraction, P = 1.45 × 10–14; Fig 3).
Similarly, diastolic dysfunction was evident by a sig-
Fig 1. End-systolic elastance pressure-volume (PV) loops. Inflow occlusion PV loops obtained from one dog. The
slope of the end-sysolic PV relationship decreases at peak HF compared with baseline. The decreased slope per-
sists at 3 months of recovery.
by 86% (potential energy, P = .01). These opposite
changes in the determinants of total PV area (a corre-
late of oxygen consumption) caused it to increase by
24%, but this was not significant. However, myocardial
mechanical efficiency, defined as the external work
(stroke work) done from the total energy within the
system (total PV area), declined significantly (P =
.00002).
After cessation of pacing, at both 8 and 12 weeks of
recovery, stroke work marginally improved (P = not
significant vs HF for 8 weeks and P < .05 vs HF for 12
weeks; Table I), but potential energy remained stable.
As a result, total PV area and myocardial efficiency
both marginally increased in parallel (P = not signifi-
cant vs HF for 8 or 12 weeks of recovery).
Discussion
Chronic tachycardia–induced HF is a reliable and
reproducible model of biventricular dilated cardiomy-
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nificant rise in relaxation rates and minimum dP/dt (τ,
P = .0013; minimum dP/dt, P = .00005; Fig 4). LV end-
diastolic pressure had increased by 155% (P < .05 vs
baseline, Fig 4). Chamber EDV had increased signifi-
cantly from 69.5 ± 4.1 mL to 125.3 ± 5.5 mL (P < .05,
Fig 2). LV mass increased significantly and remained
elevated throughout the recovery period (P = .0000007,
Fig 5). Cardiac output measured by thermodilution
decreased from 3603 ± 562 mL at baseline to 1908 ±
167 mL at peak HF (P < .05). Conversely, cardiac out-
put returned to baseline levels at 2 months of recovery.
Echocardiographic time course of recovery.
Cessation of pacing led to an increase in LV systolic
performance with small changes in LV chamber size
(Fig 2). At 2 weeks of recovery, EDVs decreased to
92% of peak failure volumes (P = 7 × 10–15), whereas
ejection fraction increased to 40.1% ± 2.2% (P < .05 vs
HF and baseline). However, as Fig 2 shows, reverse
remodeling and improvements in ejection fraction were
halted by 2 weeks of recovery. EDV and ejection frac-
tion at each subsequent biweekly interval continued to
be significantly different from baseline (P < .05).
PV analysis of recovery. PV analysis conducted at 8
weeks of recovery showed that the load-independent
index of contractility (PRSW) had also improved from
peak HF (P < .05, Fig 3) but still remained depressed
compared with baseline values (P < .05). Maximum
dP/dt and end-systolic elastance at 8 weeks were simi-
lar to those at peak failure (P = not significant) and
were significantly different from baseline values (P <
.05). Similarly, diastolic dysfunction was indicated by a
persistently elevated relaxation rate and minimum
dP/dt (P < .05 vs HF, and P < .05 vs baseline; Fig 4).
LV end-diastolic pressure had, however, returned to
baseline levels.
PV analysis at 12 weeks of recovery revealed no sig-
nificant change in systolic indices of function (end-sys-
tolic elastance, PRSW, and maximum dP/dt: all P = not
significant vs 8 weeks of recovery). In addition, all sys-
tolic indices were different from baseline values (P <
.05). Diastolic dysfunction was also persistent (P < .05
vs baseline). Finally, in a subset of dogs (n = 4) studied
at 6 months after cessation of pacing, systolic and dia-
stolic indices were similar to those seen at 12 weeks of
recovery. The nadir values of all indices at peak failure
for these 4 dogs were within the range seen for the
group.
Effects of recovery on myocardial energetics. At
peak HF, there was a 37% decrease in stroke work com-
pared with baseline (external work, P = .05; Table I). In
addition, the potential energy that was generated and
presumably dissipated as heat increased significantly
Fig 2. Echocardiographic time course of recovery after ces-
sation of rapid ventricular pacing. Biweekly echocardiograms
assessed recovery from pacing-induced failure in 7 dogs. By
peak failure (HF), there is a significant decrease in ejection
fraction (EF) and an increase in end-diastolic volume (EDV).
By 2 weeks, EF partially improves (P < .05 vs HF and base-
line [B]), but there is no further improvement thereafter (P =
not significant for 2 weeks vs 4 weeks, 4 weeks vs 6 weeks,
6 weeks vs 8 weeks, and 8 weeks vs 12 weeks). A similar pat-
tern is seen for EDV, where partial recovery is apparent by 2
weeks, but EDV is stable thereafter. 2D, Two-dimensional;
ANOVA, analysis of variance.
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Fig 3. Recovery of indices of contractility after cessation of pacing. In 9 dogs undergoing PV analysis, contrac-
tility indices of end-systolic elastance (Ees) and maximum dP/dt do not significantly improve after termination
of pacing. Preload recruitable stroke work (PRSW), however, does, but at 8 and 12 weeks of recovery it is still
significantly different from baseline values. There is no significant difference between 8 and 12 weeks of recov-
ery in any of these indices of contractility. In a subset of these dogs (n = 4), PV analysis carried out at 22 weeks
of recovery (dotted lines) showed no further improvement. Indices of LV systolic function at peak failure in this
subset were within the range seen for the group as a whole. B, Baseline; HF, heart failure; ANCOVA, analysis of
covariance; ANOVA, analysis of variance. 
Fig 4. Diastolic indices after prolonged tachycardia. In 9 dogs undergoing PV analysis, diastolic indices of min-
imum dP/dt and τ partially improve after termination of pacing but are still different from baseline (B). In a sub-
set of dogs (n = 4) studied at 22 weeks of recovery (dotted lines), no further improvement was seen. LV end-dia-
stolic pressure (LVEDP), however, returns to baseline values at 8 weeks of recovery and remains normal in the
subset of dogs studied at 22 weeks. Diastolic indices at peak failure in this subset were within the range seen for
the whole group. ANOVA, Analysis of variance.
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opathy. Within 1 week of pacing, systolic and diastolic
dysfunction are evident, and sequelae of circulatory
overload are seen shortly thereafter.1-5 Cardiac volumes
rise progressively throughout the pacing peri-
od.1,4,5,7,11,13 Loss of compensation in failure is charac-
terized by elevation of circulating neurohormones,
including catecholamines, atrial natriuretic peptide,
renin, angiotensin II, and aldosterone.3-6 On a cellular
and molecular level, chronic tachycardia results in
abnormalities in Ca++ handling, leading to systolic and
diastolic dysfunction27-31; disruption of the extracellu-
lar matrix, leading to myocyte slippage with concomi-
tant increases in cardiac volumes4,32,33; and cytoskele-
tal aberrations, leading to systolic dysfunction.4
Cessation of 2 to 4 weeks of pacing, however, is char-
acterized by a spontaneous diuresis that reduces filling
pressures to normal levels within 72 hours.1,3,4,9
Systolic function also rapidly returns to normal within
1 week,8 although Spinale and coworkers13 have shown
persistent myocyte shortening abnormalities at 4 weeks
of recovery. Prior studies have also shown disparate
recovery of systolic and diastolic function.13,15 In con-
trast to load-sensitive systolic indices, parameters of
relaxation remain altered at up to 4 weeks of recovery.
Diastolic volumes also remain elevated, and there is a
compensatory hypertrophy after discontinuation of
pacing that presumably results in a return of normal
wall stresses.13,15
We hypothesized that prolonged rapid ventricular
pacing may induce either more severe or more perma-
nent changes in the myocardium when compared with
standard shorter pacing protocols. Serial evaluation of
the heart in this study extended long beyond the cessa-
tion of pacing. The data presented here describe novel
findings that after prolonged tachycardia, global sys-
tolic and diastolic LV function remains different from
baseline for an extended period of time. In contrast to
other reports with shorter intervals of rapid ventricular
Table I. Indices of myocardial energetics
P values 
Parameter Baseline Peak failure 8-wk recovery 12-wk recovery (ANOVA)
EW (mm Hg · mL) 1266 ± 173 796 ± 120* 970 ± 111 1184 ± 136† .05
PE (mm Hg · mL) 1146 ± 139 2139 ± 200* 2054 ± 256* 2245 ± 355* .015
PV area (mm Hg · mL) 2365 ± 241 2935 ± 286 3023 ± 338 3372 ± 413 .2
Efficiency (%) 53.1 ± 5.0 26.8 ± 2.1* 32.2 ± 2.0* 35.9 ± 3.2* .00002
All data are expressed as mean ± SEM. ANOVA, Analysis of variance; EW, external work; PE, potential energy; PV, pressure-volume.
*P < .05 versus baseline, as determined by repeated-measures analysis of variance followed by the Newman-Keuls multiple comparison procedure.
†P < .05 versus peak failure, as determined by repeated-measures analysis of variance followed by the Newman-Keuls multiple comparison procedure.
Fig 5. LV hypertrophy. The LV mass, measured by means of echocardiography, increased significantly at peak
heart failure when compared with baseline values (B; P = .0000007). The hypertrophy continued at 8 and 12
weeks of recovery.
pacing, we show that maximum positive and negative
dP/dt show a small rise. PV analysis showed that the
end-systolic elastance and PRSW, which are relatively
load-independent indices of contractility, were also
abnormal. Longitudinal analysis revealed that there is
only partial LV recovery after discontinuation of pacing
seen in this study. The partial recovery that is seen is
essentially complete within 2 weeks. Also, indices of
myocardial energetics revealed a decrease in contrac-
tion efficiency at peak failure. This improved during
recovery, although not significantly, and was mediated
in part by an increase in stroke work, without a con-
comitant decrease in wasted potential energy (ie, heat
dissipated during contraction).
Consistent with past reports, persistent LV diastolic
dysfunction during recovery was demonstrated in this
study.13-15 This persistent dysfunction may be due to
permanent changes that occur in the extracellular
matrix (altering EDV), as well as in intracellular Ca++
handling (affecting intrinsic myocyte relaxation).
Although the commonly measured relaxation parame-
ters are partly dependent on loading conditions, pro-
longed relaxation seen after cessation of pacing is like-
ly due to abnormal intrinsic myocyte relaxation.4,13 In
contrast, significant dysfunction in systole seen long
after cessation of pacing in this study may require pro-
longed pacing. The additional insult of several extra
weeks of pacing may be necessary to induce permanent
changes in Ca++ homeostasis and sarcolemmal function
known to occur during rapid pacing.29,30
Potential concerns include that this study was artifi-
cially terminated at 12 weeks of recovery and that addi-
tional improvement in function could occur thereafter.
However, in a subset of dogs studied by PV analysis 6
months after cessation of rapid ventricular pacing, sys-
tolic and diastolic dysfunction was confirmed.
Although statistical comparisons were not possible in
this subset, the values of indices of function were with-
in the range seen at 12 weeks of recovery and were dif-
ferent from baseline. Thus we believe that the recovery
after prolonged pacing is incomplete and that this is a
long-term model of LV dysfunction.
Additional studies assessing cardiac responsiveness
to β-adrenergic stimulation, as well as alterations in the
neurohormonal status during recovery from prolonged
pacing, would provide further insight into recovery
from prolonged pacing. As has been shown after cessa-
tion of shorter pacing protocols, however, it is likely
that β-receptor response dysfunction is also present in
this model.13
In summary, we describe novel data on the long-term
recovery after cessation of prolonged rapid pacing,
showing persistence of significant systolic and dia-
stolic dysfunction, as well as increased ventricular vol-
umes. We also demonstrate that partial reverse remod-
eling with concomitant improvement in function in this
model is complete by 2 weeks of recovery. The stabili-
ty and the persistent dilation, as well as LV systolic and
diastolic dysfunction, make it a suitable model for the
study of novel surgical and mechanical therapies for
end-stage dilated cardiomyopathies.
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